102 related items for PubMed ID: 17609401
1. Improvement of ACTH response to insulin tolerance test in female patients with rheumatoid arthritis due to tumor necrosis factor inhibition.
Daza L, Martin-Jimenez R, De la Torre PX, Hernández E, Murillo B.
Eur J Endocrinol; 2007 Jul; 157(1):47-51. PubMed ID: 17609401
[Abstract] [Full Text] [Related]
2. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
Straub RH, Pongratz G, Schölmerich J, Kees F, Schaible TF, Antoni C, Kalden JR, Lorenz HM.
Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
[Abstract] [Full Text] [Related]
3. Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis.
Straub RH, Pongratz G, Cutolo M, Wijbrandts CA, Baeten D, Fleck M, Atzeni F, Grunke M, Kalden JR, Schölmerich J, Lorenz HM, Tak PP, Sarzi-Puttini P.
Arthritis Rheum; 2008 Apr; 58(4):976-84. PubMed ID: 18383357
[Abstract] [Full Text] [Related]
4. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.
Härle P, Straub RH, Wiest R, Mayer A, Schölmerich J, Atzeni F, Carrabba M, Cutolo M, Sarzi-Puttini P.
Ann Rheum Dis; 2006 Jan; 65(1):51-6. PubMed ID: 15941834
[Abstract] [Full Text] [Related]
5. Effects of naproxen and sulphasalazine or methotrexate on hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis.
Eijsbouts AM, Kempers MJ, van den Hoogen FH, Laan RF, Hermus AR, Ross HA, Sweep FC, van de Putte LB.
Clin Exp Rheumatol; 2011 Jan; 29(1):35-42. PubMed ID: 21345290
[Abstract] [Full Text] [Related]
6. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, Fischkoff SA, Chartash EK.
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[Abstract] [Full Text] [Related]
7. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation.
Gutiérrez MA, García ME, Rodriguez JA, Mardonez G, Jacobelli S, Rivero S.
J Rheumatol; 1999 Feb; 26(2):277-81. PubMed ID: 9972958
[Abstract] [Full Text] [Related]
8. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery.
Dökmetaş HS, Colak R, Keleştimur F, Selçuklu A, Unlühizarci K, Bayram F.
J Clin Endocrinol Metab; 2000 Oct; 85(10):3713-9. PubMed ID: 11061529
[Abstract] [Full Text] [Related]
9. In etanercept-treated psoriatic arthritis patients clinical improvement correlated with an increase of serum cortisol relative to other adrenal hormones.
Atzeni F, Sarzi-Puttini P, DePortu S, Cutolo M, Carrabba M, Straub RH.
Clin Exp Rheumatol; 2008 Oct; 26(1):103-8. PubMed ID: 18328154
[Abstract] [Full Text] [Related]
10. Hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis.
Eijsbouts AM, van den Hoogen FH, Laan RF, Hermus AR, Sweep CG, van de Putte LB.
Clin Exp Rheumatol; 2005 Oct; 23(5):658-64. PubMed ID: 16173242
[Abstract] [Full Text] [Related]
11. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis.
Jorgensen C, Bressot N, Bologna C, Sany J.
J Rheumatol; 1995 Oct; 22(10):1829-33. PubMed ID: 8991978
[Abstract] [Full Text] [Related]
12. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis.
Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, Gold PW, Chrousos GP, Wilder RL.
J Clin Endocrinol Metab; 1997 Apr; 82(4):1279-83. PubMed ID: 9100607
[Abstract] [Full Text] [Related]
13. Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol.
Straub RH, Sarzi-Puttini P, Atzeni F, Buttgereit F, Carrabba M, Cutolo M.
Ann Rheum Dis; 2005 Sep; 64(9):1353-6. PubMed ID: 15708882
[Abstract] [Full Text] [Related]
14. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis.
Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Doria A, Carrabba M.
Arthritis Res Ther; 2005 Sep; 7(2):R250-5. PubMed ID: 15743471
[Abstract] [Full Text] [Related]
15. Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry.
Atzeni F, Sarzi-Puttini P, Botsios C, Carletto A, Cipriani P, Favalli EG, Frati E, Foschi V, Gasparini S, Giardina A, Gremese E, Iannone F, Sebastiani M, Ziglioli T, Biasi D, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Gorla R, Govoni M, Lapadula G, Marchesoni A, Salaffi F, Punzi L, Triolo G, Ferraccioli G.
Autoimmun Rev; 2012 Dec; 12(2):225-9. PubMed ID: 22796281
[Abstract] [Full Text] [Related]
16. Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy.
Straub RH, Härle P, Atzeni F, Weidler C, Cutolo M, Sarzi-Puttini P.
J Rheumatol; 2005 Jul; 32(7):1253-8. PubMed ID: 15996060
[Abstract] [Full Text] [Related]
17. [Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers].
Benucci M, Turchini S, Parrochi P, Boccaccini P, Manetti R, Cammelli E, Manfredi M.
Recenti Prog Med; 2006 Mar; 97(3):134-9. PubMed ID: 16700418
[Abstract] [Full Text] [Related]
18. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor.
Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Lange M, Poulsen HS, Müller J.
J Clin Endocrinol Metab; 2003 Jul; 88(7):3149-54. PubMed ID: 12843158
[Abstract] [Full Text] [Related]
19. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids.
Cutolo M, Foppiani L, Prete C, Ballarino P, Sulli A, Villaggio B, Seriolo B, Giusti M, Accardo S.
J Rheumatol; 1999 Feb; 26(2):282-8. PubMed ID: 9972959
[Abstract] [Full Text] [Related]
20. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C, Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis.
Arthritis Rheum; 2007 May; 56(5):1417-23. PubMed ID: 17469098
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
